# Stem Cell Harvesting Using GCSF Plus Plerxiafor, in First -Line, for Heavily Pre- Treated Pediatric Oncology Patients.

> **NCT02006225** · PHASE4 · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Autologous Stem Cell Transplantation

## Interventions

- **DRUG:** Plerixafor

## Key facts

- **NCT ID:** NCT02006225
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-02
- **Primary completion:** 2019-02
- **Final completion:** 2020-02
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2013-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02006225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02006225, "Stem Cell Harvesting Using GCSF Plus Plerxiafor, in First -Line, for Heavily Pre- Treated Pediatric Oncology Patients.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02006225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*